|
|
Bioinformatics.org
|
![[?]](https://www.bioinformatics.org/images/icons/info.png)
|
|
Research
|
Online databases
Online analysis tools
Online education tools
|
|
Development
|
|
|
Forums
|
News & Commentary
Jobs Forum
(Career Center)
|
|
|
News & Commentary - Message forums
|
         
|
 |
|
At Work: Bio-IT World: 23andMe suspends sale of health tests
Submitted by J.W. Bizzaro; posted on Friday, December 06, 2013
|
EXCERPT
It appears the first chapter in the recent saga of 23andMe and FDA is now coming to a close, as 23andMe at last caves to regulatory pressure and suspends all sales of its health-related genetic tests.
An open letter from CEO Anne Wojcicki, posted last night on the 23andMe blog, reports that "23andMe will comply with FDA's directive and stop offering new consumers access to health-related genetic tests while the company moves forward with the agency's regulatory review processes."
|
|
Expanded view | Monitor forum | Save place
Start a new thread:
You have to be to post a reply.
|
|
![[University of Birmingham]](https://www.bioinformatics.org/images/ack_banners/Birmingham-728x90.gif)
![[Patsnap]](https://www.bioinformatics.org/images/ack_banners/Patsnap-728x90.png)